On January 6, 2025, the U.S. Food and Drug Administration (FDA) released draft guidance titled Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products...more
1/16/2025
/ Artificial Intelligence ,
Clinical Trials ,
Compliance ,
Digital Health ,
Draft Guidance ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Machine Learning ,
Patents ,
Pharmaceutical Industry ,
Popular ,
Regulatory Requirements ,
Risk Management ,
Trade Secrets
Looking forward to the 2025 prediction season, a survey of the emerging AI-powered drug discovery landscape has been making the rounds—and with good reason. The survey, summarized by Stanford’s Chris Bradbury, is likely the...more
12/19/2024
/ Artificial Intelligence ,
Automation Systems ,
Confidential Information ,
Cybersecurity ,
Data Collection ,
Food and Drug Administration (FDA) ,
Information Governance ,
Intellectual Property Protection ,
Medical Devices ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Privacy Laws ,
Proprietary Information ,
Regulatory Requirements ,
Trade Secrets
As companies embrace digital transformation, they increasingly depend on proprietary technologies and data that requires robust cybersecurity measures to safeguard intellectual property (IP). Zifino and Foley & Lardner LLP...more
12/17/2024
/ Artificial Intelligence ,
Compliance ,
Cyber Espionage ,
Cyber Threats ,
Cybersecurity ,
Infrastructure ,
Intellectual Property Protection ,
Patents ,
Proprietary Information ,
Supply Chain ,
Trade Secrets ,
Vulnerability Assessments
On September 28, 2024, California Governor Gavin Newson signed into law AB-2013, requiring developers of generative artificial intelligence (AI) models, under certain conditions, to make specific disclosures regarding those...more
In April 2024, BioPharmaTrend published a comprehensive review of the past and current state of artificial intelligence (AI) drug discovery, using the 2012 advent of modern deep learning as a starting point. The review...more
Nikhil Pradhan (Senior Counsel, Boston) recently joined Zebec Networks’ Future of Money podcast to explore the intersection of artificial intelligence and the blockchain ecosystem with Parth Shah. The below episode transcript...more
As recently described by The New England Journal of Medicine, the liability risks associated with using artificial intelligence (AI) in a health care setting are substantial and have caused consternation among sector...more
Major technology paradigm shifts are typically followed by a wave of patent application filings. If you don’t believe that, a quick patent search will validate this for your technology of choice.
What you’ll also find is...more
In our ever-changing technological environment, artificial intelligence (AI) is beginning to exert its influence on numerous sectors, revolutionizing our approach to work. As businesses and organizations worldwide adopt...more
10/12/2023
/ Anti-Discrimination Policies ,
Artificial Intelligence ,
Automated Decision Systems (ADS) ,
Bias ,
Biotechnology ,
Compliance ,
Confidential Information ,
Discrimination ,
Due Diligence ,
Equal Employment Opportunity Commission (EEOC) ,
Federal Trade Commission (FTC) ,
Insurance Industry ,
Intellectual Property Protection ,
Investors ,
Machine Learning ,
Misrepresentation ,
New Guidance ,
Patents ,
Personal Data ,
Purchase Agreement ,
Risk Management ,
Risk Mitigation ,
Startups ,
Strict Product Liability ,
Transparency ,
Venture Capital
Recent discussions surrounding the EU Artificial Intelligence Act have accelerated as the European Parliament took the Act one step closer to becoming effective law.
On June 14, 2023, the Parliament voted for negotiations...more
Agility and resiliency remain essential attributes for manufacturers in 2023. Manufacturers are no longer focused on figuring out when things will return to “normal.”
Instead, they are applying lessons learned from the...more
7/11/2023
/ Artificial Intelligence ,
Best Practices ,
Clawbacks ,
Compensation ,
Compliance ,
Customs and Border Protection ,
Cyber Threats ,
Cybersecurity ,
Enforcement ,
Environmental Protection Agency (EPA) ,
Final Rules ,
Intellectual Property Protection ,
Machine Learning ,
Manufacturers ,
Securities and Exchange Commission (SEC) ,
Supply Chain
Health care merger and acquisition (M&A) activity reached a significant level in 2022, even if not matching 2021’s record-breaking standard. This reflects the overall economy’s holding pattern in which resources are still...more
This article outlines a framework for creating valuable patents for protecting AI technologies, as part of a series that covers topics including why to invest in patents for AI, how to overcome the biggest challenges in...more
This is the third article in a series focused on creating a valuable patent portfolio for AI technologies, building on earlier discussions of why to invest in patents for AI and how to overcome the biggest challenges in...more
Two interwoven challenges come to mind when considering how to successfully patent AI technologies. The first of these challenges is drafting claims whose infringement is detectable despite the black box nature of AI...more
2/28/2020
/ Artificial Intelligence ,
Emerging Technology Companies ,
Intellectual Property Protection ,
Patent Applications ,
Patent Infringement ,
Patent-Eligible Subject Matter ,
Patents ,
Section 101 ,
Section 102 ,
Section 103 ,
Section 112 ,
Software Patents ,
Technology Sector ,
USPTO
Artificial intelligence has weaved its way into almost every industry, from detecting cancer to predicting employee performance to teaching robots and vehicles to use all kinds of sensor data to make human-like decisions in...more
2/20/2020
/ Artificial Intelligence ,
Business Development ,
Emerging Technology Companies ,
Intellectual Property Protection ,
Investment Management ,
Investors ,
IP License ,
IP Portfolio ,
Patent Applications ,
Patent Portfolios ,
Patents ,
Popular ,
Startups ,
Venture Capital